|
Current issue
Archive
Manuscripts accepted
About the journal
Editorial board
Abstracting and indexing
Contact
Instructions for authors
Ethical standards and procedures
Editorial System
Submit your Manuscript
 
|
3/2023
vol. 98 abstract:
Review paper
Autoimmune hepatitis and primary sclerosing cholangitis overlap syndrome in inflammatory bowel diseases
Joanna Saganek
1
,
Monika Meglicka
1
,
Aleksandra Nowakowska
1
,
Marcin Osiecki
1
,
Jarosław Kierkuś
1
Pediatr Pol 2023; 98 (3): 236-241
Online publish date: 2023/09/29
View
full text
Get citation
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
A close relationship between inflammatory bowel diseases (IBD) and hepatobiliary disorders, such as autoimmune hepatitis (AIH) and primary sclerosing cholangitis (PSC), is well established. Hepatobiliary manifestations occur in 30% of patients with IBD, and 5% develop chronic liver disease. The spectrum of symptoms of the overlap syndrome ranges from asymptomatic elevated liver function tests to serious diseases. The pathogenesis of liver complications in IBD is not fully recognized. It may either have an autoimmune background or be caused by intestinal inflammation, metabolic impairment, or drug toxicity. The aim of this review is to summarize AIH and PSC overlap syndrome in IBD.
keywords:
inflammatory bowel disease, autoimmune hepatitis, overlap syndrome, primary sclerosing cholangitis |
POLSKI
